Cargando…

The Effects of Plasma Homocysteine Level on the Risk of Three Major Psychiatric Disorders: A Mendelian Randomization Study

BACKGROUND: Higher homocysteine (Hcy) level has been suggested to be associated with major psychiatric disorders (MPDs), such as schizophrenia (SCZ), bipolar disorder (BD), and major depressive disorder (MDD). We investigated the causal relationships between plasma Hcy level and MPDs risks using the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yu, Jing, Xue, Ranran, Wang, Qiuling, Yu, Hao, Liu, Xia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Psychiatry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8977462/ https://www.ncbi.nlm.nih.gov/pubmed/35386526 http://dx.doi.org/10.3389/fpsyt.2022.841429

Ejemplares similares

Examining the Causal Inference of Leptin and Soluble Plasma Leptin Receptor Levels on Schizophrenia: A Mendelian Randomization Study
por: Chen, Guoqing, et al.
Publicado: (2021)

Cigarette smoking, coffee consumption, alcohol intake, and clozapine metabolism: A Mendelian randomization study
por: Zeng, Lingsi, et al.
Publicado: (2022)

The early life course-related traits with three psychiatric disorders: A two-sample Mendelian randomization study
por: He, Renke, et al.
Publicado: (2023)

Assessing the causal association of trauma with subsequent psychiatric disorders by a Mendelian randomization study trauma and common psychiatric disorders
por: Gu, Dongqing, et al.
Publicado: (2023)

Susceptibility and severity of COVID-19 and risk of psychiatric disorders in European populations: a Mendelian randomization study
por: Xue, Hua, et al.
Publicado: (2023)

Psychiatric traits and intracerebral hemorrhage: A Mendelian randomization study
por: Wang, Qingduo, et al.
Publicado: (2023)

A Mendelian Randomization Study of Plasma Homocysteine Levels and Cerebrovascular and Neurodegenerative Diseases
por: Liu, Weishi, et al.
Publicado: (2021)

Association Between Plasma Homocysteine Level and Mortality: A Mendelian Randomization Study
por: Choi, Chang Kyun, et al.
Publicado: (2023)

A bidirectional Mendelian randomization study about the role of morning plasma cortisol in attention deficit hyperactivity disorder
por: Jue, Hu, et al.
Publicado: (2023)

Abnormal temporal variability of rich-club organization in three major psychiatric conditions
por: Niu, Meng, et al.
Publicado: (2023)

Plasma homocysteine levels and risk of congestive heart failure or cardiomyopathy: A Mendelian randomization study
por: Wang, Xinyi, et al.
Publicado: (2023)

A Mendelian Randomization Study of Plasma Homocysteine and Multiple Myeloma
por: Xuan, Yang, et al.
Publicado: (2016)

Transcriptomics and magnetic resonance imaging in major psychiatric disorders
por: Fan, Jing-Wen, et al.
Publicado: (2023)

An exploration of the correlations between seven psychiatric disorders and the risks of breast cancer, breast benign tumors and breast inflammatory diseases: Mendelian randomization analyses
por: Ren, Fei, et al.
Publicado: (2023)

Duloxetine in Psychiatric Disorders: Expansions Beyond Major Depression and Generalized Anxiety Disorder
por: Muscatello, Maria Rosaria Anna, et al.
Publicado: (2019)

Investigating the causal effects of smoking, sleep, and BMI on major depressive disorder and bipolar disorder: a univariable and multivariable two-sample Mendelian randomization study
por: He, Menglin, et al.
Publicado: (2023)

Metabolic risk factors of cognitive impairment in young women with major psychiatric disorder
por: Zhuo, Chuanjun, et al.
Publicado: (2022)

Cognitive Distortions in Relation to Plasma Cortisol and Oxytocin Levels in Major Depressive Disorder
por: Thomas, Susan Jennifer, et al.
Publicado: (2020)

Commentary: Targeting the MRI-mapped psychopathology of major psychiatric disorders with neurostimulation
por: Xie, Jia-Xin, et al.
Publicado: (2022)

The potency of psychiatric questionnaires to distinguish major mental disorders in Chinese outpatients
por: Wang, Jiayi, et al.
Publicado: (2022)

Gyrification patterns in first-episode, drug-naïve major depression: Associations with plasma levels of brain-derived neurotrophic factor and psychiatric symptoms
por: Natsuyama, Tomoya, et al.
Publicado: (2023)

Transdiagnostic association between subjective insomnia and depressive symptoms in major psychiatric disorders
por: Nakajima, Suguru, et al.
Publicado: (2023)

DISC1 Pathway in Brain Development: Exploring Therapeutic Targets for Major Psychiatric Disorders
por: Kamiya, Atsushi, et al.
Publicado: (2012)

“Immune Gate” of Psychopathology—The Role of Gut Derived Immune Activation in Major Psychiatric Disorders
por: Rudzki, Leszek, et al.
Publicado: (2018)

Plasma Metabolomics Profiling of Metabolic Pathways Affected by Major Depressive Disorder
por: Du, Yue, et al.
Publicado: (2021)

Reduced Plasma Levels of α-Klotho and Their Correlation With Klotho Polymorphisms in Elderly Patients With Major Depressive Disorders
por: Gao, Xiang, et al.
Publicado: (2021)

Evaluation of an association between plasma total homocysteine and schizophrenia by a Mendelian randomization analysis
por: Numata, Shusuke, et al.
Publicado: (2015)

Patient-Level Predictors of Psychiatric Readmission in Substance Use Disorders
por: Böckmann, Volker, et al.
Publicado: (2019)

Causal effects of homocysteine levels on the components of sarcopenia: A two-sample mendelian randomization study
por: Yu, Hongwei, et al.
Publicado: (2022)

Non-targeted Metabolomics Profiling of Plasma Samples From Patients With Major Depressive Disorder
por: Wu, Zhonghao, et al.
Publicado: (2022)

Intestinal metabolites and the risk of autistic spectrum disorder: A two-sample Mendelian randomization study
por: Liu, Deyang, et al.
Publicado: (2023)

The relationship between COVID-19, depressive disorder, and anxiety: a bidirectional Mendelian randomization study
por: Zihao, Liang, et al.
Publicado: (2023)

Glutamatergic Dysfunction and Glutamatergic Compounds for Major Psychiatric Disorders: Evidence From Clinical Neuroimaging Studies
por: Li, Cheng-Ta, et al.
Publicado: (2019)

Alterations of Plasma Lipids in Adult Women With Major Depressive Disorder and Bipolar Depression
por: Zhang, Ting, et al.
Publicado: (2022)

Preliminary Study on Changes of Sleep EEG Power and Plasma Melatonin in Male Patients With Major Depressive Disorder After 8 Weeks Treatment
por: Wang, Xue-Qin, et al.
Publicado: (2021)

Exploring the Causal Pathway From Telomere Length to Alzheimer’s Disease: An Update Mendelian Randomization Study
por: Gao, Kai, et al.
Publicado: (2019)

A Preliminary Investigation on Plasma Cell Adhesion Molecules Levels by Protein Microarray Technology in Major Depressive Disorder
por: Liu, Wanying, et al.
Publicado: (2021)

Increased plasma levels of IL-6 are associated with striatal structural atrophy in major depressive disorder patients with anhedonia
por: Lu, Shaojia, et al.
Publicado: (2022)

The Homocysteine and Metabolic Syndrome: A Mendelian Randomization Study
por: Lee, Ho-Sun, et al.
Publicado: (2021)

Appraising the Causal Association of Plasma Homocysteine Levels With Atrial Fibrillation Risk: A Two-Sample Mendelian Randomization Study
por: Chen, Songzan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_kde0vug6jvi3ih9m7jauohkf8e